Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB...

  • Main
  • 2018 / 11
  • Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB...
Journal of Neuromuscular Diseases 2018 / 11

Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy

Finanger, Erika, Vandenborne, Krista, Finkel, Richard S., Lee Sweeney, H., Tennekoon, Gihan, Yum, Sabrina, Mancini, Maria, Bista, Pradeep, Nichols, Andrew, Liu, Hanlan, Fretzen, Angelika, Donovan, Joa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Neuromuscular Diseases
DOI:
10.3233/JND-180341
Date:
November, 2018
File:
PDF, 345 KB
english, 2018
Conversion to is in progress
Conversion to is failed